Pharma Journalist -

SMi are thrilled to welcome Dr. Noreen Roth Henig, Chief Medical Officer, ProQR Therapeutics onto the speaker panel RNA Therapeutics 2018! ProQR is dedicated to discovering and…
Read More...

Evotec AG and TESARO, Inc. announced a three-year integrated drug discovery collaboration to discover and develop novel small molecule product candidates against an undisclosed…
Read More...

BioMarin Pharmaceutical announced that the U.S. Food and Drug Administration (FDA) granted valoctocogene roxaparvovec (formerly BMN 270) Breakthrough Therapy Designation. The FDA's…
Read More...

PDL BioPharma announced that it has submitted a proposal to acquire Neos Therapeutics for $10.25per share in cash. This all-cash transaction represents a premium of 40% to the…
Read More...

Artemis Therapeutics announced the appointment of Brian M. Culley, M.A., M.B.A. as its Chief Executive Officer. Mr. Culley is an entrepreneurial and innovative biotech executive with 25…
Read More...

Incyte Corporation and MacroGenics, Inc. announced that the companies have entered into an exclusive global collaboration and license agreement for MacroGenics’ MGA012, an…
Read More...

Ortek Therapeutics announced that the Ortek ECD™ received 510(k) clearance from the U.S. Food and Drug Administration. The ECD is a patented lightweight tabletop device designed as an…
Read More...

TiGenix NV announces that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Cx601 for the treatment of patients with fistulizing Crohns disease.…
Read More...

Imprimis Pharmaceuticals announced that it is making compounded Cyclosporine-based formulations available for physicians to consider prescribing as customizable and potentially…
Read More...

Catalent announced that it has completed the acquisition of Cook Pharmica LLC, an integrated provider of drug substance and drug product manufacturing and related services. The…
Read More...